Literature DB >> 17585879

The NMR solution structure of recombinant RGD-hirudin.

Xia Song1, Wei Mo, Xingang Liu, Lina Zhu, Xiaomin Yan, Houyan Song, Linsen Dai.   

Abstract

The solution structure of a new recombinant RGD-hirudin, which has the activities of anti-thrombin and anti-platelet aggregation, was determined by (1)H nuclear magnetic resonance spectroscopy and compared with the conformations of recombinant wild-type hirudin and hirudin (variant 2, Lys47) of the hirudin thrombin complex. On the basis of total 1284 distance and dihedral angle constraints derived from a series of NMR spectra, 20 conformers were computed with ARIA/CNS programs. The structure of residues 3-30 and 37-48 form a molecular core with two antiparallel beta-sheets as the other two hirudins. However, significant differences were found in the surface electrostatic charge distributions among the three hirudins, especially in the RGD segment of recombinant RGD-hirudin. This difference may be greatly beneficial to its additional function of anti-platelet aggregation. The difference in extended C-terminal makes its both ionic and hydrophobic interactions with the fibrinogen recognition exosite of thrombin more effective.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17585879     DOI: 10.1016/j.bbrc.2007.06.014

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Proton bridging in the interactions of thrombin with hirudin and its mimics.

Authors:  Ildiko M Kovach; Lazaros Kakalis; Frank Jordan; Daoning Zhang
Journal:  Biochemistry       Date:  2013-04-01       Impact factor: 3.162

Review 2.  Proton Bridging in Catalysis by and Inhibition of Serine Proteases of the Blood Cascade System.

Authors:  Ildiko M Kovach
Journal:  Life (Basel)       Date:  2021-04-27

3.  Expression, purification, and mass spectrometric analysis of 15N, 13C-labeled RGD-hirudin, expressed in Pichia pastoris, for NMR studies.

Authors:  Yinong Huang; Yanling Zhang; Yi Wu; Jue Wang; Xingang Liu; Linsen Dai; Longsheng Wang; Min Yu; Wei Mo
Journal:  PLoS One       Date:  2012-08-07       Impact factor: 3.240

4.  Structural basis of RGD-hirudin binding to thrombin: Tyr3 and five C-terminal residues are crucial for inhibiting thrombin activity.

Authors:  Yinong Huang; Yanling Zhang; Bing Zhao; Qiping Xu; Xiushi Zhou; Houyan Song; Min Yu; Wei Mo
Journal:  BMC Struct Biol       Date:  2014-12-20

5.  Revisiting antithrombotic therapeutics; sculptin, a novel specific, competitive, reversible, scissile and tight binding inhibitor of thrombin.

Authors:  Asif Iqbal; Mauricio Barbugiani Goldfeder; Rafael Marques-Porto; Huma Asif; Jean Gabriel de Souza; Fernanda Faria; Ana Marisa Chudzinski-Tavassi
Journal:  Sci Rep       Date:  2017-05-03       Impact factor: 4.379

6.  RGD-hirudin-based low molecular weight peptide prevents blood coagulation via subcutaneous injection.

Authors:  Ya-Ran Li; Yi-Nong Huang; Bing Zhao; Meng-Fang Wu; Tian-Yu Li; Yan-Ling Zhang; Di Chen; Min Yu; Wei Mo
Journal:  Acta Pharmacol Sin       Date:  2020-01-16       Impact factor: 6.150

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.